KRAS inhibitor 11 structure
|
Common Name | KRAS inhibitor 11 | ||
---|---|---|---|---|
CAS Number | 900897-56-5 | Molecular Weight | 413.515 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C25H27N5O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of KRAS inhibitor 11KRAS inhibitor 11 is a first-in-class, high-affinity, noncovalent allosteric KRAS inhibitor, disrupts KRAS-Raf interaction with Kd of 1.2 uM; binds to activated KRAS with sub-micromolar affinity and disrupts effector binding, thereby inhibiting KRAS signaling and cancer cell growth; dose-dependently decreases both p-ERK and p-cRaf levels in BHK cells expressing KRASG12D and KRASG12V, suggesting inhibition of RAS signaling via the MAPK pathway. |
Name | 2-[4-(2-Methyl-3,5-diphenylpyrazolo[1,5-a]pyrimidin-7-yl)-1-piperazinyl]ethanol |
---|---|
Synonym | More Synonyms |
Description | KRAS inhibitor 11 is a first-in-class, high-affinity, noncovalent allosteric KRAS inhibitor, disrupts KRAS-Raf interaction with Kd of 1.2 uM; binds to activated KRAS with sub-micromolar affinity and disrupts effector binding, thereby inhibiting KRAS signaling and cancer cell growth; dose-dependently decreases both p-ERK and p-cRaf levels in BHK cells expressing KRASG12D and KRASG12V, suggesting inhibition of RAS signaling via the MAPK pathway. |
---|---|
References | References 1. McCarthy MJ, et al. ACS Omega. 2019 Feb 28;4(2):2921-2930. View Related Products by Target Ras |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C25H27N5O |
Molecular Weight | 413.515 |
Exact Mass | 413.221558 |
LogP | 2.90 |
Index of Refraction | 1.672 |
2-[4-(2-Methyl-3,5-diphenylpyrazolo[1,5-a]pyrimidin-7-yl)-1-piperazinyl]ethanol |
1-Piperazineethanol, 4-(2-methyl-3,5-diphenylpyrazolo[1,5-a]pyrimidin-7-yl)- |